Assenagon Asset Management
ORGO icon

Assenagon Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Assenagon Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.78M Hold
1,967,952
– – 0.01% 671
2026
Q1 		$4.66M Sell
1,967,952
-3,567,382
-64% -$12.4M 0.01% 601
2025
Q4 		$28.7M Buy
5,535,334
+680,392
+14% +$3.3M 0.04% 304
2025
Q3 		$20.5M Buy
4,854,942
+1,997,038
+70% +$9.28M 0.03% 365
2025
Q2 		$10.5M Buy
2,857,904
+2,520,941
+748% +$9.4M 0.02% 453
2025
Q1 		$1.46M Sell
336,963
-2,613,886
-89% -$10.6M ﹤0.01% 821
2024
Q4 		$9.44M Buy
2,950,849
+1,035,120
+54% +$3.47M 0.02% 530
2024
Q3 		$5.48M Sell
1,915,729
-2,061,395
-52% -$5.78M 0.01% 701
2024
Q2 		$11.1M Buy
3,977,124
+3,005,450
+309% +$8.07M 0.02% 414
2024
Q1 		$2.76M Hold
971,674
– – 0.01% 765
2023
Q4 		$3.97M Hold
971,674
– – 0.01% 702
2023
Q3 		$3.09M Sell
971,674
-393,523
-29% -$1.25M 0.01% 705
2023
Q2 		$4.53M Hold
1,365,197
– – 0.02% 526
2023
Q1 		$2.91M Sell
1,365,197
-74,843
-5% -$185K 0.01% 717
2022
Q4 		$3.87M Sell
1,440,040
-570,407
-28% -$1.66M 0.01% 597
2022
Q3 		$6.51M Buy
2,010,447
+7,120
+0.4% +$32.2K 0.03% 428
2022
Q2 		$9.78M Buy
2,003,327
+352,685
+21% +$2.17M 0.04% 370
2022
Q1 		$12.6M Buy
1,650,642
+380,389
+30% +$2.94M 0.03% 311
2021
Q4 		$11.7M Buy
1,270,253
+140,051
+12% +$1.49M 0.03% 296
2021
Q3 		$16.1M Buy
1,130,202
+226,137
+25% +$3.51M 0.05% 230
2021
Q2 		$15M Buy
904,065
+1,360
+0.2% +$25.4K 0.05% 267
2021
Q1 		$16.4M Buy
+902,705
New +$12.2M 0.07% 242
2019
Q3 		– Sell
-17,341
Closed -$132K – 1011
2019
Q2 		$132K Buy
+17,341
New +$128K ﹤0.01% 962

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Assenagon Asset Management's ORGO Position: Q2 2026 in Review

Assenagon Asset Management held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 1,967,952 shares worth $4.78M. The position accounts for 0.01% of the portfolio, ranked #671.

Assenagon Asset Management first reported a position in ORGO in Q2 2019 and has held it in 23 quarters since. The position peaked at $28.7M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Assenagon Asset Management held 1,967,952 shares of Organogenesis Holdings worth $4.78M as of Q2 2026.
  • Assenagon Asset Management left its Organogenesis Holdings share count unchanged in Q2 2026.
  • Organogenesis Holdings made up 0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #671 holding.
  • Assenagon Asset Management first reported a position in Organogenesis Holdings in Q2 2019 and has held it in 23 quarters since.
  • Assenagon Asset Management's Organogenesis Holdings position peaked at $28.7M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.